Nanjing Vishee Medical Technology Co., Ltd (SHA:688580)
China · Delayed Price · Currency is CNY 48.20
-0.70 (-1.43%)
Jun 11, 2026, 3:00 PM CST
SHA:688580 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 166.43 | 138.07 | 101.97 | 136.26 | 93.83 | 177.81 |
Depreciation & Amortization | 27.27 | 27.27 | 21.98 | 20.14 | 17.14 | 11.08 |
Other Amortization | 2.02 | 2.02 | 1.43 | 1.84 | 1.68 | 0.38 |
Loss (Gain) From Sale of Assets | 0 | 0 | -0 | 0 | - | - |
Asset Writedown & Restructuring Costs | - | - | 0.01 | 0.01 | 0.01 | 0.01 |
Loss (Gain) From Sale of Investments | -17.37 | -17.37 | -13.76 | -9.62 | -16.01 | -20.56 |
Provision & Write-off of Bad Debts | 0.84 | 0.84 | 1.44 | 2.27 | 0.68 | 0.89 |
Other Operating Activities | -33.13 | 1.73 | 1.18 | 1.24 | 0.33 | -0.09 |
Change in Accounts Receivable | -35.6 | -35.6 | 7.77 | -21.77 | 7.32 | -13.14 |
Change in Inventory | -3.9 | -3.9 | 1.15 | -5.08 | 1.81 | 6.67 |
Change in Accounts Payable | 61.71 | 61.71 | -9.17 | -3.48 | -20.13 | -18.96 |
Change in Other Net Operating Assets | 2.48 | 2.48 | 3.47 | 19.65 | -2.83 | 21.37 |
Operating Cash Flow | 170.24 | 176.74 | 118.29 | 134.2 | 86.17 | 157.37 |
Operating Cash Flow Growth | 29.65% | 49.42% | -11.86% | 55.74% | -45.24% | 30.31% |
Capital Expenditures | -163.98 | -118.12 | -113.08 | -133.48 | -95.61 | -87.34 |
Sale of Property, Plant & Equipment | 112.99 | 41.65 | 0.02 | 0 | - | - |
Cash Acquisitions | -29.65 | -29.65 | - | -20.11 | -34.19 | - |
Investment in Securities | -349.96 | -49.96 | - | -23 | - | - |
Other Investing Activities | 10.96 | 12.58 | 12.24 | 12.48 | 25.01 | 10.56 |
Investing Cash Flow | -419.64 | -143.49 | -100.82 | -164.11 | -104.8 | -76.79 |
Long-Term Debt Repaid | - | -0.88 | -1.55 | -1.35 | -14.87 | -1.35 |
Net Debt Issued (Repaid) | -0.88 | -0.88 | -1.55 | -1.35 | -14.87 | -1.35 |
Issuance of Common Stock | - | - | 13.32 | - | 10.79 | - |
Repurchase of Common Stock | - | - | -13.64 | -11.58 | -2.02 | - |
Common Dividends Paid | -76.57 | -76.57 | -102.2 | -51.04 | -88.91 | -71.83 |
Dividends Paid | -76.57 | -76.57 | -102.2 | -51.04 | -88.91 | -71.83 |
Other Financing Activities | - | - | - | - | - | -7.81 |
Financing Cash Flow | -77.45 | -77.45 | -104.07 | -63.96 | -95.01 | -80.99 |
Foreign Exchange Rate Adjustments | -0.09 | -0.04 | 0 | - | - | - |
Net Cash Flow | -326.93 | -44.24 | -86.59 | -93.87 | -113.64 | -0.41 |
Free Cash Flow | 6.26 | 58.63 | 5.21 | 0.72 | -9.45 | 70.02 |
Free Cash Flow Growth | -78.17% | 1024.89% | 627.46% | - | - | -35.82% |
Free Cash Flow Margin | 1.32% | 12.67% | 1.30% | 0.15% | -2.94% | 16.28% |
Free Cash Flow Per Share | 0.07 | 0.61 | 0.06 | 0.01 | -0.10 | 0.73 |
Cash Income Tax Paid | 37.31 | 35.68 | 44.52 | 41.82 | 40.12 | 50.52 |
Levered Free Cash Flow | -99.2 | 21.73 | 8.41 | -26.08 | -15.43 | -4.02 |
Unlevered Free Cash Flow | -98.6 | 22.55 | 9.23 | -25.26 | -15.22 | -3.91 |
Change in Working Capital | 24.17 | 24.17 | 4.05 | -17.94 | -11.5 | -12.16 |